Open access
100
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
Leah B Sansbury1 Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, Durham, NC, USAView further author information
, Kieran J Rothnie2 Value and Evidence Outcomes, GlaxoSmithKline, Uxbridge, UKView further author information
, Chanchal Bains3 Real World Evidence and Epidemiology, GlaxoSmithKline, Uxbridge, UKView further author information
, Chris Compton4 Global Respiratory Franchise, GlaxoSmithKline, Brentford, UKView further author information
, Glenn Anley2 Value and Evidence Outcomes, GlaxoSmithKline, Uxbridge, UKView further author information
& Afisi S Ismaila5 Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA;6 Department of Health Research Methods, McMaster University, Hamilton, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-2876-8308View further author information
Pages 2591-2604
|
Published online: 15 Sep 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.